Sep 2026
A Retrospective Post-Marketing Surveillance Study on TGlobulin25®, the First Rabbit Anti-Thymocyte Globulin (r-ATG) Biosimilar Worldwide, as Induction Therapy in Adult Kidney Transplant Recipients
A post-marketing surveillance investigation comparing TGlobulin25 with the originator product regarding efficacy and safety in adult kidney transplant recipients found no statistically significant differences in major efficacy and safety outcomes.
M. Shafiekhani, Mohammad Amin Jafarzadeh, F. Shahabinezhad et al.
· Iranian Journal of Medical S... · 0 citations